Literature DB >> 26947768

Repeated significance tests of linear combinations of sensitivity and specificity of a diagnostic biomarker.

Mixia Wu1, Yu Shu2, Zhaohai Li3, Aiyi Liu4.   

Abstract

A sequential design is proposed to test whether the accuracy of a binary diagnostic biomarker meets the minimal level of acceptance. The accuracy of a binary diagnostic biomarker is a linear combination of the marker's sensitivity and specificity. The objective of the sequential method is to minimize the maximum expected sample size under the null hypothesis that the marker's accuracy is below the minimal level of acceptance. The exact results of two-stage designs based on Youden's index and efficiency indicate that the maximum expected sample sizes are smaller than the sample sizes of the fixed designs. Exact methods are also developed for estimation, confidence interval and p-value concerning the proposed accuracy index upon termination of the sequential testing. Published 2016. This article is a U.S. Government work and is in the public domain in the USA. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  Youden's index; expected sample size; inference upon early stopping; sensitivity; sequential testing; specificity; two-stage designs; type I error

Mesh:

Substances:

Year:  2016        PMID: 26947768      PMCID: PMC4938793          DOI: 10.1002/sim.6932

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  20 in total

Review 1.  Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests.

Authors:  M Greiner; D Pfeiffer; R D Smith
Journal:  Prev Vet Med       Date:  2000-05-30       Impact factor: 2.670

2.  Optimal designs of two-stage studies for estimation of sensitivity, specificity and positive predictive value.

Authors:  Roseanne McNamee
Journal:  Stat Med       Date:  2002-12-15       Impact factor: 2.373

3.  Prospective studies of diagnostic test accuracy when disease prevalence is low.

Authors:  Nancy A Obuchowski; Xiao-Hua Zhou
Journal:  Biostatistics       Date:  2002-12       Impact factor: 5.899

4.  A decision-theoretic evaluation of early stopping rules.

Authors:  D F Heitjan; P S Houts; H A Harvey
Journal:  Stat Med       Date:  1992-03       Impact factor: 2.373

5.  A sequential design to estimate sensitivity and specificity of a diagnostic or screening test.

Authors:  Lisa M Wruck; Constantin T Yiannoutsos; Michael D Hughes
Journal:  Stat Med       Date:  2006-10-30       Impact factor: 2.373

6.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

7.  Optimal two-stage designs for phase II clinical trials.

Authors:  R Simon
Journal:  Control Clin Trials       Date:  1989-03

8.  Bivariate sequential designs for phase II trials.

Authors:  M R Conaway; G R Petroni
Journal:  Biometrics       Date:  1995-06       Impact factor: 2.571

9.  Efficient study designs to assess the accuracy of screening tests.

Authors:  L Irwig; P P Glasziou; G Berry; C Chock; P Mock; J M Simpson
Journal:  Am J Epidemiol       Date:  1994-10-15       Impact factor: 4.897

10.  Admissible two-stage designs for phase II cancer clinical trials.

Authors:  Sin-Ho Jung; Taiyeong Lee; KyungMann Kim; Stephen L George
Journal:  Stat Med       Date:  2004-02-28       Impact factor: 2.373

View more
  1 in total

1.  Sensitivity, Specificity, Predictive Values, and Accuracy of Three Diagnostic Tests to Predict Inferior Alveolar Nerve Blockade Failure in Symptomatic Irreversible Pulpitis.

Authors:  Daniel Chavarría-Bolaños; Laura Rodríguez-Wong; Danny Noguera-González; Vicente Esparza-Villalpando; Mauricio Montero-Aguilar; Amaury Pozos-Guillén
Journal:  Pain Res Manag       Date:  2017-06-14       Impact factor: 3.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.